What Pfizer Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 3 |
| Sells | 1 | 2 |
| Total trades | 4 | 33 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 114,863 | 933,757 |
| Disposed | 3,278 | 789,814 |
| Net activity | +111,585 | +143,943 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bourla Albert | Chairman & CEO | Aug 12 | Open-market buy · P | +38,000 | $26.34 | +$1M | 429,173 |
| Damico Jennifer B. | SVP & Controller | Aug 05 | Open-market sale · S | −3,278 | $25.40 | −$83.3K | 28,611 |
| Blaylock Ronald E | Director | Aug 05 | Open-market buy · P | +39,231 | $25.46 | +$999K | 66,938 |
| Buckley Mortimer J | Director | Aug 05 | Open-market buy · P | +37,632 | $25.52 | +$960K | 37,632 |
| Damico Jennifer B. | SVP & Controller | Jun 09 | Open-market sale · S | −2,000 | $25.70 | −$51.4K | 31,397 |
| Damico Jennifer B. | SVP & Controller | Mar 04 | Withheld — tax / exercise cost · F | −826 | $26.62 | −$22K | 32,934 |
| Damico Jennifer B. | SVP & Controller | Mar 03 | Grant / award · A | +5,408 | — | — | 33,760 |
| Damico Jennifer B. | SVP & Controller | Mar 03 | Grant / award · A | +16,311 | — | — | 28,352 |
| Damico Jennifer B. | SVP & Controller | Feb 27 | Withheld — tax / exercise cost · F | −655 | $27.65 | −$18.1K | 12,041 |
| McDermott Michael | Executive Vice President | Feb 26 | Withheld — tax / exercise cost · F | −3,503 | $27.10 | −$94.9K | 74,308 |
| Fonseca Lidia | Executive Vice President | Feb 25 | Withheld — tax / exercise cost · F | −54,066 | $26.92 | −$1.46M | 46,455 |
| Fonseca Lidia | Executive Vice President | Feb 25 | Withheld — tax / exercise cost · F | −1,058 | $27.09 | −$28.7K | 100,521 |
| Fonseca Lidia | Executive Vice President | Feb 25 | Exercise / conversion · M | +56,888 | $33.82 | +$1.92M | 101,579 |
| Bourla Albert | Chairman & CEO | Feb 25 | Withheld — tax / exercise cost · F | −467,241 | $26.92 | −$12.6M | 388,671 |
| Bourla Albert | Chairman & CEO | Feb 25 | Withheld — tax / exercise cost · F | −8,303 | $27.09 | −$225K | 855,912 |
| Bourla Albert | Chairman & CEO | Feb 25 | Exercise / conversion · M | +491,626 | $33.82 | +$16.6M | 864,215 |
| Damico Jennifer B. | SVP & Controller | Feb 25 | Withheld — tax / exercise cost · F | −16,687 | $26.92 | −$449K | 12,696 |
| Damico Jennifer B. | SVP & Controller | Feb 25 | Withheld — tax / exercise cost · F | −361 | $27.09 | −$9.78K | 29,383 |
| Damico Jennifer B. | SVP & Controller | Feb 25 | Exercise / conversion · M | +17,558 | $33.82 | +$594K | 29,744 |
| Boshoff Christoffel | President, R&D | Feb 25 | Withheld — tax / exercise cost · F | −6,833 | $27.09 | −$185K | 161,379 |
Loading...
